Related Experiment Video
Updated: Jun 27, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
An ounce of prevention: the potential for value-based pharmacy benefits in cost containment
1Watson Wyatt Worldwide, New York City, USA.
Abstract:
A growing number of companies are considering whether they can reduce overall medical costs by improving drug compliance through value-based pharmacy benefit designs. Value-based designs either provide more generous coverage for certain clinically proven drugs, or change cost-sharing or copayment levels for drugs used to treat the employee population's most widespread and costly chronic medical problems. This article presents employer experiences, identifies important issues for those considering value-based pharmacy benefits and suggests ways to overcome barriers to implementation.
Related Concept Videos
Preventive Healthcare Services
Pharmaceutical Poisoning: Potential Scenarios
Prevention of Further Absorption of Poison
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...